Moleculin Biotech (MBRX) Institutional Ownership $1.03 -0.03 (-2.36%) As of 02:02 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Moleculin Biotech (NASDAQ:MBRX)CurrentInstitutional OwnershipPercentage15.52%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$26.42KNumber ofInstitutional Sellers(last 12 months)0 Get MBRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Moleculin Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MBRX Institutional Buying and Selling by Quarter Moleculin Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024Armistice Capital LLC156,000$549K0.0%+5.1%6.747% 2/13/2024Armistice Capital LLC3,207,417$2.75M0.0%N/A9.600% 1/17/2024 Atticus Wealth Management LLC50,001$43K0.0%N/A0.168% 5/15/2023Sio Capital Management LLC1,010,956$971K0.5%-2.5%3.407% 7/25/2022 Walker Asset Management LLC20,708$32K0.0%N/A0.072% 4/20/2022Sigma Planning Corp57,500$102K0.0%+33.7%0.201% 2/2/2022Sigma Planning Corp43,000$80K0.0%N/A0.150% 11/9/2021BlackRock Inc.270,402$812K0.0%-2.5%0.947% 9/17/2021Virtu Financial LLC25,302$93K0.0%N/A0.089% 8/16/2021Occudo Quantitative Strategies LP29,188$107K0.0%+31.7%0.102% 8/16/2021State Street Corp59,900$220K0.0%N/A0.210% 8/13/2021Geode Capital Management LLC237,586$871K0.0%+35.9%0.835% 8/13/2021Vanguard Group Inc.1,047,529$3.84M0.0%+123.6%3.683% 8/12/2021XTX Topco Ltd32,997$121K0.0%N/A0.116% 8/5/2021GSA Capital Partners LLP31,120$114K0.0%N/A0.109% 5/21/2021Citadel Advisors LLC13,843$56K0.0%N/A0.049% 5/19/2021Squarepoint Ops LLC28,904$118K0.0%+134.2%0.102% 5/18/2021Cubist Systematic Strategies LLC26,624$109K0.0%N/A0.094% 5/18/2021Citadel Advisors LLC13,843$56K0.0%N/A0.049% 5/14/2021Occudo Quantitative Strategies LP22,158$90K0.0%N/A0.078% 5/12/2021Northern Trust Corp50,731$207K0.0%-43.1%0.178% 5/12/2021Geode Capital Management LLC174,822$713K0.0%-40.6%0.615% 5/7/2021BlackRock Inc.239,326$977K0.0%+449.7%0.841% 4/27/2021 Harel Insurance Investments & Financial Services Ltd.10,000$136K0.0%N/A0.035% (Data available from 1/1/2016 forward) MBRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MBRX shares? During the previous two years, the following institutional investors and hedge funds held shares of Moleculin Biotech shares: Sio Capital Management LLC ($971K), and Armistice Capital LLC ($549K), Atticus Wealth Management LLC ($43K).Learn more on MBRX's institutional investors. What percentage of Moleculin Biotech stock is owned by institutional investors? 15.52% of Moleculin Biotech stock is owned by institutional investors. Learn more on MBRX's institutional investor holdings. Which institutional investors have been buying Moleculin Biotech stock? The following institutional investors have purchased Moleculin Biotech stock in the last 24 months: Armistice Capital LLC ($3.21M), and Atticus Wealth Management LLC ($50.00K). How much institutional buying is happening at Moleculin Biotech? Institutional investors have bought a total of 3,264,923 shares in the last 24 months. This purchase volume represents approximately $41.97M in transactions. Which Moleculin Biotech major shareholders have been selling company stock? The following institutional investors have sold Moleculin Biotech stock in the last 24 months: Sio Capital Management LLC ($25.90K). How much institutional selling is happening at Moleculin Biotech? Institutional investors have sold a total of 25,897 shares in the last 24 months. This volume of shares sold represents approximately $372.92K in transactions. Related Companies FBLG Institutional Ownership RPTX Institutional Ownership ONCY Institutional Ownership PEPG Institutional Ownership IMRX Institutional Ownership PDSB Institutional Ownership SKYE Institutional Ownership GANX Institutional Ownership ICCC Institutional Ownership CUE Institutional Ownership This page (NASDAQ:MBRX) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moleculin Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moleculin Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
